BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng Z, Guan R, Jianxi W, Zhao Z, Peng T, Liu C, Lin Y, Jian Z, Wu YS. Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/9567041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang SY, Feng JK, Zou M, Guo WX. Response to: "Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues". Hepatol Int 2023. [PMID: 36871099 DOI: 10.1007/s12072-023-10485-1] [Reference Citation Analysis]
2 Lv C, He N, Yang JJ, Xiao JJ, Zhang Y, Du J, Zuo S, Li HY, Gu H. Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study. Br J Radiol 2023;:20220702. [PMID: 36745047 DOI: 10.1259/bjr.20220702] [Reference Citation Analysis]
3 Feng LH, Zhu YY, Zhou JM, Wang M, Wang L, Xu WQ, Zhang T, Mao AR, Cong WM, Dong H, Wang L. A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis. Ann Surg Oncol 2023;30:363-72. [PMID: 36151430 DOI: 10.1245/s10434-022-12598-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zheng Z, Guan R, Zou Y, Jian Z, Lin Y, Guo R, Jin H. Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience. J Inflamm Res 2022;15:5089-102. [PMID: 36091335 DOI: 10.2147/JIR.S378099] [Reference Citation Analysis]
5 Zheng Y, Huang X, Shi H. Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues. Hepatol Int 2022. [PMID: 36002715 DOI: 10.1007/s12072-022-10413-9] [Reference Citation Analysis]
6 Bai S, Hu L, Liu J, Sun M, Sun Y, Xue F. Prognostic Nomograms Combined Adjuvant Lenvatinib for Hepatitis B Virus–related Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection. Front Oncol 2022;12:919824. [DOI: 10.3389/fonc.2022.919824] [Reference Citation Analysis]